Table 2.
Introduced chemical(s) | Cell type | Source | Experiment | ALP activity | Mineralization | Gene/Protein marker 1 | References | ||
---|---|---|---|---|---|---|---|---|---|
Inflammatory Cytokines
(TNFα and IL-1β) |
DPSC | Human | In vitro | - | N |
ALP, NES, and DSPP *The results were verified by NF-κB knock-down. |
Hozhabri et al. [32] | ||
Strontium | DPSC | Human | In vitro | + | + | DSPP, RUNX2, OCN, MEPE, BMP2, and ON | Huang et al. [33] | ||
Ca 2+ | DPSC | Human | In vitro | - | + |
BSP/BSP, OCN/OCN, DMP1, and DSPP *BMP/Smad pathway is involved in the Ca2+-induced odontoblast-like differentiation of DPSCs. |
Li et al. [34] | ||
LPS | DPSC | Human | In vitro | N | + |
OCN, DMP1, DSPP, and ALP *LPS promotes odontoblast-like differentiation via TLR4, ERK, and P38 MAPK signaling pathways. |
He et al. [35] | ||
BMP2 | DPSC | Human | In vitro, in vivo | N | + |
DSPP, DMP1, PHEX, MMP20 *Increased odontoblast-like cells, vascularization, and dentin matrix formation were observed at the areas, in which treated cells were transplanted. |
Atalayin et al. [36] | ||
MMP2-CLEAVAGE OF DMP1 | DPSC | Human | In vitro, in vivo | N | N |
DSP, DMP1 *Implantation of this peptide in a rat injured pulp model resulted in dentin-like structure formation. |
Chaussain et al. [37] | ||
FGF2 and
TGF- β |
DPSC | Human | In vitro | + | + |
DSP/DSP, DMP1/DMP1 * FGF and TGF-β co-treatment improves odontoblast-like differentiation inducing potential. |
Unda et al. [97] | ||
Insulin-like growth factor | DPSC | Human | In vitro | + | + | OSX/OSX, RUNX2/RUNX2, OCN/OCN, DSPP, DSP | LV et al. [38] | ||
Platelet lysate | DPSC | Human | In vitro, in vivo | + | + | N | Chen et al. [39] | ||
Semaphorin 4D | DPSC | Human | In vitro | - | - | COL1/COL1, DSPP/DSPP, ALP, BSP, RUNX2 | Zou et al. [40] | ||
Recombinant LOXL2 | DPSC | Human | In vitro | - | - | ALP, DMP1, and DSPP | Kim et al. [41] | ||
Trichostatin A
(histone deacetylase inhibitor) |
DPSC | Human | In vitro, in vivo | + | + | DSPP, DMP1, BSP | Jin et al. [42] | ||
EDTA
(cells were seeded on dentin slices) |
DPSC | Human | In vitro | N | + |
DMP1 and DSPP *EDTA induced cell attachment. |
Pang et al. [43] | ||
Ca(OH)
2
and NaOCl &EDTA
(cells were seeded on dentin slices) |
DPSC | Human | In vitro | N | N |
DSPP and DMP1 *Ca(OH)2 and EDTA promoted the differentiation of DPSCs after NaOCl treatment. |
Park et al. [44] | ||
Conditioned dentine slice and powder
by EDTA, phosphoric acid, citric acid |
DPSC | Human | In vitro | N | + | ALP and OPN | Sadaghiani et al. [45] | ||
Ethanol | DPSC | Human | In vitro, in vivo | - | - |
BMP2, BMP4, OCN, OPN, ALP, DLX2 *Ethanol induced inhibition of KDM6B (a lysine demethylase). As a result, odontogenic differentiation is down regulated. |
Hoang et al. [46] | ||
Preameloblast-conditioned medium | DPSC | Human | In vitro, in vivo | N | + | DSP, NES, COL1 | Lee et al. [47] | ||
Human and swine tooth germ cell conditioned medium | DPSC | Human | In vitro, in vivo | + | + | OPN, DSPP, DMP1/DMP1, OCN, BSP, DSP | Wang et al. [48] | ||
Ginsenoside Rg1 | DPSC | Human | In vitro | N | N | BMP2/BMP2, FGF2/FGF2, DSPP, ALP, OCN | Wang et al. [49] | ||
Zinc containing bioactive glasses | DPSC | Human | In vitro | + | + | RUNX2, OCN, MEPE, BMP2, BSP, ON, DSPP, DMP1 | Huang et al. [50] | ||
MTA | DPSC | Human | In vitro | N | N |
BSP, ALP, OCN, COL1, DSPP *MTA can induce odontoblast-like differentiation via mitogen-activated protein kinase pathway. |
Zhao et al. [51] | ||
MTA | DPSC | Hunan | In vitro | N | + |
DMP1 and DSPP *Microarray analysis is done and list of differentially expressed genes which their differences are more than 4-fold are shown. |
Seo et al. [52] | ||
MTA and CEM | DPSC | Human | In vitro | N | + |
DSPP, DMP1, BMP2, TGF-β1, FGF4 *These chemicals stimulate different gene expression. |
Asgary et al. [53] | ||
MTA | SCAP | Human | In vitro, in vivo | + | + |
OCN/OCN, RNX2/RUNX2, ALP, DSPP, DSP *MTA can induce odontoblast-like differentiation via Nuclear Factor Kappa B signaling pathway. |
Yan et al. [54] | ||
HEMA and TEDGMA | SCAP | Human | In vitro | - | - | BSP, OCN, DSPP | Bakopoulou et al. [55] | ||
Basic FGF | SCAP | Human | In vitro | - | - |
BSP, ALP, OCN, OCN, DSPP *This growth factor increases stemness of hSCAPs. |
Wu et al. [56] | ||
Insulin-like growth factor | SCAP | Human | In vitro, in vivo | + | + | OCN/OCN, OSX/OSX, RUNX2/RUNX2, ALP | DSPP, DSP | Wang et al. [57] | |
BMP2 | SCAP | Human | In vitro, in vivo | + | + |
BSP, OCN, COL1, and DSPP *Seeding cells on nanofibrous microspheres (NF-MS) in combination with controlled release of BMP-2 results in more mineralized tissue formation. |
Wang et al. [58] | ||
Recombinant human plasminogen activator inhibitor-1 | SCAP | Human | In vitro, in vivo | + | + | ALP, COL1, OPN, OCN, BSP, DMP1 | Jin et al. [59] | ||
Conditioned medium from periapical follicle cells | SCAP | Human | In vitro | + | + | DSPP, ALP, OCN | Wu et al. [60] | ||
Dexamethasone-releasing chitosan nanoparticle
(Conditioned dentine) |
SCAP | Human | In vitro | N | + | DMP1 and DSPP *Increasing dexamethasone releasing velocity results in odontogenic differentiation inducing potential. |
Shrestha et al. [61] | ||
Platelet lysate | DPSC, SCAP | Human | In vitro | + | + |
DSPP, OPN *SCAPs show more potential for odontogenic differentiation. |
Abuarqoub et al. [62] | ||
Platelet-rich plasma | DPSC, PDLSC | Human | In vitro | + | + | BSP, OPN, CEMP1, and DSPP | Lee et al. [63] | ||
BMP2 and dental slice scaffold | SHED | Human | In vitro, in vivo | N | N |
DSPP, DMP1, MEPE
*After BMP treatment, SHED express BMP receptors. |
Casagrande et al. [64] | ||
MEPE-derived ASARM (phosphorylated form) | SHED | Human | In vitro, in vivo | N | - | ALP, MEPE/MEPE | DSPP, DSP, OCN/OCN | Salmon et al. [65] | |
HEMA and TEDGMA | SHED | Human | In vitro | - | - | BSP, ALP, OCN, DSPP | Bakopoulou et al. [66] | ||
EMD | TGSC | Human | In vitro | + | N | DSPP | Guven et al. [67] | ||
MTA | - | DSPP | |||||||
Aminated mesoporous bioactive nanoparticles | DPSC | Rat | In vitro | + | + | BSP, OCN, COL1, DMP1 and DSPP | Lee et al. [68] | ||
TNF-α | BMP9-Induced SCAPs | Rat | In vitro, in vivo | - | - | OCN, OPN | Wang et al. [69] |
(Chemicals, Proteins, and Genes; TNF-α: tumor necrosis factor alpha, IL-1β: Interleukin 1 beta, LPS: Lipopolysaccharide, BMP: bone morphogenetic protein, MMP: matrix metalloproteinase, DMP: Dentin matrix acidic phosphoprotein, FGF: fibroblast growth factor, TGF-β: transforming growth factor β, LOXL1: Lysyl oxidase homolog 1, EDTA: Ethylenediaminetetraacetic acid, MTA: mineral trioxide aggregate, HEMA: 2-hydroxyethyl methacrylate, TEDGMA: Tri-ethylene-glycol-dimethacrylate, MEPE: Matrix extracellular phosphoglycoprotein, ASARM: serine- and aspartic acid-rich motif, EMD: enamel matrix derivative, ALP: alkaline phosphatase, NES: Nestin, DSPP: dentin sialophosphoprotein, Runx2: Runt-related transcription factor 2, OCN: osteocalcin, ON: osteonectin, BSP: bone sialoprotein, PHEX: Phosphate-regulating neutral endopeptidase, X-linked, DSP: dentin sialoprotein, OSX: Transcription factor Sp7 which is also called Osterix, COL1: Collagen type I, OPN: osteopontin, DLX: Distalless, CEMP: cementum protein. Cells; DPSCs: dental pulp stem cells, SCAP: stem cells from the apical papilla, PDLSC: periodontal ligament stem cells, SHED: stem cells from exfoliated deciduous teeth, TGSC: tooth germ stem cells. Assays; (+): significant increase compared to control group, (-): significant decrease compared to control group, N: not evaluated.)
1: Regular cells represent gene/protein marker upregulation, shaded cells represent gene/protein marker downregulation.